Double test (first trimester prenatal screening, 11+0 to 13+6 weeks)
The double test is first-trimester prenatal screening, done from 11 weeks to 13 weeks and 6 days of pregnancy. It measures PAPP-A and free beta-hCG in the mother’s blood and, together with the ultrasound measurement of nuchal translucency and the mother’s details, estimates the baby’s risk of trisomies 21, 18 and 13.
Preparation and sampling
- Preparation
- Guide to preparing for tests
- Sample
- Blood
- Where it is done
- All laboratories and map
Description
About the test
The double test is a first-trimester prenatal screening test. It is done between 11 weeks and 13 weeks and 6 days of pregnancy and is used to estimate the risk of chromosomal conditions in the baby, mainly trisomy 21 (Down’s syndrome), trisomy 18 (Edwards’ syndrome) and trisomy 13 (Patau’s syndrome). It is part of first-trimester combined screening, which brings together three sources of information:
- two biochemical markers in the mother’s blood, free beta-hCG and PAPP-A;
- the ultrasound scan, above all the measurement of nuchal translucency (the thickness of the fluid at the back of the baby’s neck) and of the baby’s length (CRL), from which the length of pregnancy is determined accurately;
- the mother’s details: age, weight, smoking, how the pregnancy was conceived (including IVF) and previous pregnancies.
All this information is entered into statistical software that calculates an individual risk for each of the three trisomies. None of these on its own is sufficient, but together they give a much more reliable estimate.
PAPP-A (pregnancy-associated plasma protein A) is a protein made mainly by the placenta; it contributes to the normal development of the placenta and the healthy growth of the baby in the first months of pregnancy, and its level normally rises as pregnancy progresses. Low levels in the first trimester can be linked to an increased risk of chromosomal conditions, particularly trisomies 21 and 18, and also to later pregnancy complications such as growth restriction of the baby and pre-eclampsia.
Free beta-hCG is the free beta subunit of human chorionic gonadotrophin, a hormone made by the placenta that is important for maintaining early pregnancy. In trisomy 21 its levels are often raised, and in trisomies 18 and 13 often low.
The double test does not make a diagnosis; it gives a statistical estimate of risk.
When it is recommended
- as routine prenatal screening in the first trimester of pregnancy;
- to estimate the risk of trisomies 21, 18 and 13;
- for pregnant women aged 35 and over;
- for women who had a baby with a chromosomal condition in a previous pregnancy;
- when an ultrasound scan shows signs that may point to a condition in the baby.
Preparation
- The blood sample is taken between 11 weeks and 13 weeks and 6 days of pregnancy.
- You do not need to fast.
- Bring your first-trimester ultrasound report with the measured length of the baby (CRL), the nuchal translucency (NT) and the date of the scan. For a more accurate result, it is best for the scan and the blood test to be done as close together as possible, ideally within 24 hours.
- Have ready the details used in the risk calculation: your date of birth, weight, whether you smoke, whether you have diabetes, whether the pregnancy was achieved by IVF, the number of babies and details of previous pregnancies.
Sample
Venous blood from the mother.
Reference values
PAPP-A and free beta-hCG are not reported against a usual reference range but as MoM (multiples of the median): they are compared with the values expected for the same length of pregnancy, adjusted for the mother’s characteristics. The cut-offs depend on the method and on the risk calculation software, and interpretation is based on combining the biochemical and ultrasound findings into an individual risk.
Reference values depend on the method and the laboratory; the values printed on your report apply to your result.
Interpreting the results
The result is expressed as an individual risk for each trisomy, for example 1 in 250 or 1 in 1000 (the larger the second number, the lower the risk).
- Low risk – a low probability of major chromosomal conditions; it does not rule them out completely.
- High risk – an increased probability of trisomy 21, 18 or 13. Further assessment is needed: a non-invasive prenatal test (NIPT) on the mother’s blood or invasive diagnosis (chorionic villus sampling or amniocentesis), together with a discussion with the gynaecologist.
- Trisomy 21 typically shows raised free beta-hCG with low PAPP-A, while trisomies 18 and 13 show low levels of both markers.
- A low PAPP-A with normal chromosomes may indicate an increased risk of later pregnancy complications, so the doctor may adjust the monitoring of the pregnancy.
Your doctor interprets the result together with your symptoms and other findings.
What can affect the result
For most of the following factors the risk calculation software makes an adjustment, so it is important that the details entered are correct:
- an incorrectly estimated length of pregnancy;
- a twin pregnancy;
- maternal obesity;
- maternal diabetes;
- smoking;
- a pregnancy achieved by IVF;
- errors in the details entered into the risk calculation software;
- a blood sample taken outside the period from 11 weeks to 13 weeks and 6 days, or a long gap between the ultrasound scan and the blood test.
Related tests
- the first-trimester ultrasound scan (nuchal translucency), an integral part of combined screening;
- a non-invasive prenatal test (NIPT) on the mother’s blood, with greater accuracy for trisomies 21, 18 and 13;
- the triple or quadruple test in the second trimester, when first-trimester screening was not done;
- amniocentesis, an invasive procedure that examines the baby’s chromosomes directly;
- chorionic villus sampling, an invasive first-trimester procedure that gives a definite genetic diagnosis.
Frequently ordered together
How to order tests online?
Choose the tests you need and add them to your cart. Use the site search to find the tests you want more easily.
Payment method:
- Online – payment uses 3D-Secure, a secure authentication protocol that minimises the risk of fraud.
- At the laboratory – order your tests online and pay for them when you come to the laboratory.
After payment, you will receive an email confirming your order, with details of how to prepare for sampling. From then on, you can go to the Sante laboratory you chose when ordering your tests and have your samples taken.